Mechanical Circulatory Assist Devices

2019 ◽  
pp. 424-428
Author(s):  
Ayan Sen ◽  
Bhavesh M. Patel
Keyword(s):  
Heart Failure ◽  
Heart Function ◽  
Decompensated Heart Failure ◽  
Destination Therapy ◽  
Bridge To Recovery ◽  
Assist Devices ◽  
Bridge To Transplant ◽  
Circulatory Assist Devices ◽  
Bridge To Decision ◽  
Tissue Circulation

Mechanical circulatory assist devices (MCADs) are used in patients with decompensated heart failure refractory to medical therapy. The devices are used as a bridge to transplant, as a bridge to recovery for reversible conditions, as a bridge to decision while a patient’s eligibility for transplant is determined, and as destination therapy to support left-sided heart function when a patient is not eligible for transplant. MCADs restore tissue circulation by increasing blood flow and, thereby, improving organ function.

scholarly journals Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure

2015 ◽  
Vol 9s1 ◽  
pp. CMC.S19701 ◽  
Author(s):  
William E. Lawson ◽  
Michael Koo
Keyword(s):  
Heart Failure ◽  
Acute Decompensated Heart Failure ◽  
Decompensated Heart Failure ◽  
Mechanisms Of Action ◽  
Ventricular Assist Devices ◽  
Bridge To Recovery ◽  
Future Directions ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Support Devices

The successful treatment of acute decompensated heart failure continues to evolve with an increasing utilization of nondurable mechanical support devices. Indications for acute support have broadened to include their use as a bridge to recovery or decision (for durable ventricular assist devices [VADs] or heart transplant). Available devices have improved in terms of effectiveness, ease of insertion, and reduction in complications. The commonly used devices (intra-aortic balloon pump, TandemHeart, Impella, and extracorporeal membrane oxygenation circuit), together with their mechanisms of action, are reviewed. Current considerations for support, specific to each device, are examined and future directions and indications for percutaneous VADs are explored.

Circulatory Assist Devices in Congestive Heart Failure

1994 ◽  
Vol 12 (1) ◽  
pp. 143-154 ◽  
Author(s):  
Timothy V. Votapka ◽  
D. Glenn Pennington
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Assist Devices ◽  
Circulatory Assist Devices

Current Perspectives on the Use of Circulatory Assist Devices

1991 ◽  
Vol 2 (3) ◽  
pp. 488-499
Author(s):  
Richard G. Smith ◽  
Marilyn Cleavinger
Keyword(s):  
Implantable Devices ◽  
National Institutes Of Health ◽  
Assist Devices ◽  
Bridge To Transplant ◽  
Circulatory Assist Devices ◽  
Patients With Heart Failure ◽  
Reasonable Cost ◽  
Ongoing Development ◽  
Near Future

An overview of currently available circulatory assist devices (CADs) is presented with discussion of each system’s optimal use and limitations. Successful application of CAD technology for bridge to transplant or pending recovery of the natural heart requires understanding issues involving team readiness, patient selection, device limitations, patient management, and complications. Currently, many of these devices are in clinical trials with the Food and Drug Administration (FDA). The FDA and the National Institutes of Health play major roles in the ongoing development of this technology. In the near future the learning curve continues as totally implantable systems are used. The ultimate goal is to maintain patients with heart failure on implantable devices with a good quality of life at a reasonable cost

scholarly journals Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy

2017 ◽  
Vol 9 ◽  
pp. 117906521771421 ◽  
Author(s):  
Gabriel A Hernandez ◽  
Jonatan D Nunez Breton ◽  
Sandra V Chaparro
Keyword(s):  
Treatment Options ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Destination Therapy ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Bridge To Transplant ◽  
Innovative Therapy

Advances in mechanical circulatory support devices provided the technology to develop long-term, implantable left ventricular assist devices as bridge to transplant, destination therapy, and in a lesser group of patients, as bridge to recovery. Despite the benefits from this innovative therapy, with their increased use, many complications have been encountered, one of the most common being infections. With the driveline acting as a portal to the exterior environment, an infection involving this structure is the most frequent one. Because patients with destination therapy are expected to receive circulatory support for a longer period of time, we will focus this review on the risk factors, prevention, and treatment options for driveline infections.

scholarly journals Current Trends in Implantable Left Ventricular Assist Devices

2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Jens Garbade ◽  
Hartmuth B. Bittner ◽  
Markus J. Barten ◽  
Friedrich-Wilhelm Mohr
Keyword(s):  
Heart Failure ◽  
Selection Process ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Destination Therapy ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

The shortage of appropriate donor organs and the expanding pool of patients waiting for heart transplantation have led to growing interest in alternative strategies, particularly in mechanical circulatory support. Improved results and the increased applicability and durability with left ventricular assist devices (LVADs) have enhanced this treatment option available for end-stage heart failure patients. Moreover, outcome with newer pumps have evolved to destination therapy for such patients. Currently, results using nonpulsatile continuous flow pumps document the evolution in outcomes following destination therapy achieved subsequent to the landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure Trial (REMATCH), as well as the outcome of pulsatile designed second-generation LVADs. This review describes the currently available types of LVADs, their clinical use and outcomes, and focuses on the patient selection process.

Sign in / Sign up

Export Citation Format

Share Document